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Activated macrophages play an important role in many
inflammatory diseases. However, the molecular mechanisms
controlling macrophage activation are not completely under-
stood. Here we report that a novel CCCH-zinc finger protein
family, MCPIP1, 2, 3, and 4, encoded by four genes, Zc3h12a,
Zc3h12b, Zc3h12c, and Zc3h12d, respectively, regulates macro-
phage activation. Northern blot analysis revealed that the
expression ofMCPIP1 andMCPIP3 was highly induced inmac-
rophages in response to treatment with lipopolysaccharide
(LPS). Although not affecting cell surface marker expression
and phagocytotic function, overexpression of MCPIP1 signifi-
cantly blunted LPS-induced inflammatory cytokine and NO2.
production as well as their gene expression. Conversely, short
interfering RNA-mediated reduction in MCPIP1 augmented
LPS-induced inflammatory gene expression. Further studies
demonstrated that MCPIP1 did not directly affect the mRNA
stability of tumor necrosis factor  andmonocyte chemoattrac-
tant protein 1 (MCP-1) but strongly inhibited LPS-induced
tumornecrosis factor and inducible nitric-oxide synthase pro-
moter activation. Moreover, we found that forced expression of
MCPIP1 significantly inhibited LPS-induced nuclear factor-B
activation. These results identify MCP-induced proteins, a
novelCCCH-zinc finger protein family, as negative regulators in
macrophage activation and may implicate them in host immu-
nity and inflammatory diseases.
Macrophages play an important role in many inflammatory
disease states, including atherosclerosis, rheumatoid arthritis,
emphysema, pulmonary fibrosis, and chronic pancreatitis. In
these disease settings activated macrophages elaborate a large
array of cytokines, growth factors, and proteolytic enzymes that
are critical for tissue damage and repair (1). Numerous extra-
cellular inducers of macrophage activation have been identi-
fied, among the most studied of which are lipopolysaccharide
(LPS)2 and interferon  (IFN) (2). LPS is a structurally heter-
ogenous material contained within the cell wall of Gram-nega-
tive bacteria and is recognized by animals as a molecule corre-
lating to infection. It binds to Toll-like receptor 4 (TLR4),
triggering multiple signaling cascades including those medi-
ated through the transcription factor NF-B and the Janus
N-terminal kinase and p38 kinase pathways (3).
Much attention has focused on the pro-inflammatory signaling
in activated macrophages but little is known about the mecha-
nisms that negatively control inflammation. Understanding the
molecularmechanisms involved in the inflammatory processes in
macrophages is essential to the development of novel drug thera-
pies against inflammatory diseases, including atherosclerosis.
Previously, we identified a novel CCCH-zinc finger-contain-
ing protein that was significantly induced by MCP-1 in human
peripheral blood monocytes and thus designated as MCP-in-
duced protein (MCPIP) (4). By searching the similar sequences
in GenBankTM, we found that four members belong to this
protein family, designated as MCPIP1, 2, 3, and 4 and encoded
by four genes, Zc3h12a, Zc3h12b, Zc3h12c, and Zc3h12d,
respectively. The obvious feature of this protein family is that
they all contain a single CCCH-type zinc finger and their func-
tion remains unknown.
Zinc finger proteins comprise a large superfamily. It is esti-
mated that 1% of all mammalian genes encode zinc fingers.
There are at least 14 different types of fingers, categorized by
the nature and spacing of their zinc-chelating residues. Most
zinc fingers are CCHH or CCCC type (referred to as classical
zinc fingers). CCCH-type zinc finger-containing proteins are
very unusual in mammalian genomes and represent 0.8% of
all zinc finger-containing proteins (5, 6). A well studied CCCH-
zinc finger protein family is the tristetraprolin (TTP, also
known as Zfp36) family, which also contains four members,
TTP, Zfp36l1, Zfp36l2, and Zfp36l3. This protein family con-
tains two tandemCCCH-zinc fingers and binds to AU-rich ele-
ments inmRNA, leading to the removal of the poly(A) tail from
that mRNA and increased rates of mRNA turnover (7–9). ZAP,
which is also a CCCH-type zinc finger protein, can bind to viral
RNA to cause profound and specific loss of viral mRNA (10).
Roquin, another CCCH-zinc finger protein, functions as a
ubiquitin ligase and is required to repress autoimmunity (11).
In this study, we found that the members of theMCPIP fam-
ily were dramatically induced by LPS in macrophages. Overex-
pression of MCPIP1 significantly attenuated LPS-induced
inflammatory cytokine and NO2. production and their gene
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expression, perhaps by antagonizing NF-B signaling. These
results indicate that they may be novel regulators in macro-
phage activation.
MATERIALS AND METHODS
Mice—Male C57BL/6 wild-type mice (6–8 weeks old)
were purchased from The Jackson Laboratories (Bar Harbor,
ME) andhoused in a temperature-controlled environmentwith
12-h light/dark cycles at the University of Central Florida
Transgenic Animal Facility in accordancewith the principles of
animal care of the National Institutes of Health. These studies
were reviewed and approved by the Institutional Animal Care
and Use Committee of the University of Central Florida.
Cells—The mouse macrophage cell line RAW264.7 was
obtained from American Type Culture Collection (ATCC) and
maintained in RPMI 1640 supplemented with 2 mM glutamine,
100 units/ml of penicillin and streptomycin, and 10% fetal bovine
serum (FBS) (endotoxin 1 ng/ml) (Sigma). The human acute
monocytic leukemia cell line THP-1 was obtained from ATCC
andmaintained inRPMI1640mediumwith2mML-glutamine, 1.5
g/liter sodiumbicarbonate, 4.5 g/liter glucose, 10mMHEPES, and
1.0mM sodium pyruvate and supplemented with 0.05mM 2-mer-
captoethanol, 10% FBS. THP-1 cells were stimulated with 100
nM/liter phorbol 12-myristate 13-acetate for 5days todifferentiate
into macrophages and then were quiescent for 16–24 h by being
cultured inmacrophage serum-free medium (Invitrogen).
Mouse bone marrow-derived macrophages were generated
from bone marrow stem cells obtained from femurs of male
C57BL/6 mice (2–4 months old). After lysis of the red blood
cells, 4  106 of bone marrow stem cells were inoculated in
6-well plates with complete Dulbecco’s modified Eagle’s
medium culture medium containing 10% FBS, 30% L929 con-
ditional medium, and standard supplements. After 7 days of
culture, the fullydifferentiatedandmaturedbonemarrow-derived
macrophages were quiescent for 24 h in macrophage serum-free
medium and then treated with 1 g/ml LPS for different time
points. Human embryonic kidney 293 cells were cultured in Dul-
becco’s modified Eagle’s medium supplemented with 2mM gluta-
mine, 100 units/ml of penicillin and streptomycin, and 10% FBS.
Plasmids—Human MCPIP1 expression plasmid (pMCPIP1)
was generated as described previously (4). An open reading
frameof humanMCPIP1was ligated to theN terminus of EGFP
within the vector pEGFP-N1 by using EcoRI and BamHI. In the
transient transfection experiment, pEGFP-N1 was used as a
control. Wt (containing human -globin gene) and Wt-
TNF (containing -globin gene and the potent ARE from
tumor necrosis factor  mRNA in the 3-untranslated region)
were kindly provided by Dr. Jens Lykke-Andersen (University
of Colorado, Boulder) (12). TNF-Luc plasmid was a gift
from Dr. Dmitry Kuprash (Russian Academy of Science)
(13). iNOS-Luc and PPRE-TK-Luc were from the laboratory
of Dr. Mangelsdorf (UT Southwestern, Dallas, TX). NF-B-
TK-Luc was purchased from Stratagene (La Jolla, CA).
Reagents—The MCPIP1 rabbit polyclonal antibody was pre-
pared against the human recombinant MCPIP1 protein as
described previously (4). B7-1 (sc-1632) and actin antibody
were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Rhodamine-conjugated goat anti-rabbit IgG was from
Chemicon International (Temecula, CA). LPS (Escherichia coli
026:B6-derived), human recombinant interferon-, and actino-
mycin D were purchased from Sigma. Doxycycline was from
Clontech (Mountain View, CA).
Transfection—For functional study, transient transfection
into Raw264.7 cells was performed by electroporation follow-
ing themanufacturer’s instruction (Amaxa). Briefly, RAW264.7
cells were grown to confluence in RPMI 1640 medium supple-
mented with 10% FBS. Cells were collected and washed once
with RPMI 1640 medium and resuspended with the electropo-
ration buffer (Amaxa). After electroporation, the cells were
plated on 6-well plates and the transfection efficiency was
monitored by fluorescent microscopy. Over 60% cells were
GFP-positive. Transient transfection into HEK293 cells was
performed using Lipofectamine 2000 according to the man-
ufacturer’s instruction.
For promoter analysis, Raw264.7 cells were seeded into
12-well plates and transfected with FuGENE 6 transfection rea-
gent (Roche Applied Science) following the manufacturer’s
instruction. The total amount of plasmid DNA was kept con-
stant within each experiment. Luciferase activity wasmeasured
by the luciferase assay system (Promega) and normalized to
-galactosidase activity by co-transfecting the pCMV-gal
plasmid in all experiments. All transfections were performed in
triplicate and repeated at least two times.
RNA Isolation and Northern Blot—Total RNA was isolated
from cells using RNA STAT-60 reagent (Tel-Test, Friend-
swood, TX) following the manufacturer’s instruction. 15 g of
total RNA was denatured and electrophoresed on 1% agarose-
formaldehyde gels. The uniformity of sample loading was verified
by UV visualization of the ethidium bromide-stained gel before
transfer toNylonmembrane. The cDNAprobes forMCPIP1, 2, 3,
and 4 were amplified by PCR using individual cDNA clones from
ATCC as templates. 32P-labeled cDNA was prepared using the
random priming method (Invitrogen). Hybridization was per-
formed using QuickHyb buffer (Stratagene) at 65 °C for 2 h or
overnight. The membranes were then washed once with 2 SSC
and once with 0.1 SSC, 1% SDS for 20min at 65 °C.
Quantitative Real-time PCR—After removing the genomic
DNA using DNase I (Ambion), 2.4 g of total RNA from
RAW264.7 or bone marrow-derived macrophage cells was
reverse-transcribed to cDNA using a commercially available kit
(Applied Biosystems). Quantitative real-time PCRwas performed
with iCycler Thermal Cycler (Bio-Rad) using 2 SYBR Green
master mix (Bio-Rad). Forty cycles were conducted as follows:
95 °C for 30 s, 60 °C for 30 s, preceded by 1 min at 95 °C for poly-
merase activation. Primer sequences for all genes wemeasured in
this report are available upon request. Quantification was per-
formed by the delta cycle time method, with -actin used for
normalization.
Protein Isolation and Western Blot—After washing twice
with PBS, cells were gently scraped with a rubber policeman
into 5ml of ice-cold PBS and centrifuged at 1,000  g for 5 min
at 4 °C. Cells from each 10-cm dish were then resuspended and
lysed in 0.5 ml of lysis buffer containing 50 mM NaH2PO4, pH
7.6, 250 mMNaCl, 50 mMNaF, 10 mM imidazole, 0.5% Nonidet
P-40, 1 g/ml leupeptin, and 1 mM phenylmethylsulfonyl fluo-
ride. The cell lysate was left on ice for 20 min and then soni-
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cated and centrifuged at 10,000  g for 10 min at 4 °C. Nuclear
and cytoplasmic extracts were prepared using NE-PERNuclear
andCytoplasmic Extraction kit (Pierce) following themanufac-
turer’s instruction. Protein concentrations were determined by
the Bradford method (Bio-Rad) with bovine serum albumin as
the standard. For Western blotting, proteins (50 g) were sep-
arated by SDS-PAGE and transferred onto nitrocellulosemem-
branes in transfer buffer containing 0.1% SDS. Themembranes
were blocked with 5% nonfat dry milk in 0.05% Tween 20 in
Tris-buffered saline (TTBS) for 2 h and incubated with the pri-
mary antiserum at a 1:1,000 dilution in the blocking buffer for
1 h. After being washed with TTBS three times for 10min each,
the membranes were incubated with a 1:2,000 dilution of sec-
ondary antibody in TTBS for 1 h. Following three 10-min
washes with TTBS, membranes were incubated with SuperSig-
nal West Pico Chemiluminescent Substrate (Pierce) and
exposed to x-ray film.
Immunocytochemistry—THP-1 cells were grown on glass
coverslips under the conditions described above. After differ-
entiation intomacrophages, the cells were treatedwith or with-
out LPS (1 g/ml) for 16 h. The cells were then washed with
ice-cold PBS three times before being fixed at room tempera-
ture for 10 min in 4% (w/v) paraformaldehyde in PBS. Cells
were againwashedwith PBS twice and permeabilizedwith 0.2%
(v/v) Triton X-100 in TBS at room temperature for 10min. The
cells were incubated at 4 °C overnight in anti-MCPIP1 serum
(1:200 dilution) and 1% normal goat serum in 0.1 M sodium
phosphate buffer, pH7.4. Following twowasheswith 0.2% (w/v)
Triton X-100 in TBS, the cells were incubated at room temper-
ature for 1 h in goat anti-rabbit IgG rhodamine-conjugated sec-
ondary antibody (1:200 dilution; Chemicon) and 25% normal
goat serum in TBS. The cells were rinsed twice with PBS for 10
min each time before being mounted with Vectashield mount-
ing medium (Vector Laboratories, Burlingame, CA). The slides
were examined and imaged with a Nikon fluorescence micro-
scope (Zeiss, Thornwood, NY).
Determination of TNF, IL-6, andNOProduction—NOrelease
was spectrophotometrically determined by measuring the accu-
mulation of nitrite in the medium 8 h after cell activation using
GriessReagent System (Promega). TNF and IL-6weremeasured
using enzyme-linked immunosorbent assay kits (eBioscience).
Ac-LDL Uptake—Raw264.7 cells were transfected with
pMCPIP1 and pEGFP-N1. 24 h later the cells were treated with
Dil-labeled ac-LDL (Biomedical Technologies, Inc.) for the
time periods indicated, subsequently washed twice with PBS,
and lysed in isopropanol. After sonication followed by 10min of
centrifugation (13,000  g), Dil-labeled ac-LDL content was
measured by fluorometry. For microscopy, cells were cultured
on glass slides and treated with Dil-labeled ac-LDL.
mRNA Stability Assay—Two approaches were used tomeas-
ure the mRNA stability. First, Raw264.7 cells were transfected
with pMCPIP1 and pEGFP-N1. After 8 h of stimulation with
LPS (1 g/ml), transcription was stopped by adding 5 g/ml
actinomycin D. The cells were harvested and RNAwas isolated
at different time points as indicated.mRNA level wasmeasured
by Northern blot. Second, HeLa Tet-off cells were transfected
with Wt or Wt-TNF reporters and pMCPIP1 or
pEGFP-N1 in the presence of 50 ng/ml doxycycline using
FuGENE 6 transfection reagent (Roche Applied Science). 24 h
later, a transcription pulse from the reportermRNA expression
plasmid was initiated by washing cells with PBS and feeding
with 2 ml of Dulbecco’s modified Eagle’s medium/10% FBS,
containing no doxycycline. 6 h later, 3g/ml of doxycyclinewas
added to stop transcription. The cells were harvested and RNA
was isolated at different time points as indicated. -Globin
mRNA level was measured by Northern blot (12).
Short Interference RNA—The pre-designed short interfer-
ence RNA targeting to mouse MCPIP1 (ID number 170484) as
well as its negative control were purchased fromAmbion (Aus-
tin, TX). The short interference RNA was transfected into
Raw264.7 cells by electroporation using Amaxa Electropora-
tion Unit following the manufacturer’s instruction. 24 h later,
the cells were treatedwith orwithout LPS (1g/ml) for 8 h. The
cells were then harvested and RNA was isolated to assess for
MCPIP1 knock down and target gene expression.
Statistics—Data were expressed as mean  S.D. For comparison
between twogroups, theunpairedStudent’s testwasused. Formulti-
ple comparisons, analysis of variance followed by unpaired Student’s
testwas used.A value ofp 0.05was considered significant.
RESULTS
Identification of theMCPIP Protein Family—MCP-1 not only
attractsmonocytes from the blood stream into the vascularwall
but also actively regulates gene expression and contributes to
FIGURE 1. Identification of the MCPIP family. A, schematic representation of
the structures of the mouse MCPIP protein family. The conserved domains
were indicated. B, the amino acid sequences of the CCCH-type zinc finger
from the mouse MCPIP family and TTP were aligned by consensus ClustalW
sequence alignment using DNASTAR. The amino acids CCCH have been
boxed, and the other identical amino acids have been shaded. C, bioinformatic
information of both human and mouse MCPIP family was summarized from
the NCBI data base. The name for each gene was designated in this study. The
other name appeared in the data base. Chr., chromosome.
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the pathogenesis of inflammatory
diseases. In an effort to searchMCP-
1-induced genes in human mono-
cytes using gene microarray analy-
sis, we previously identified a highly
MCP-1-induced gene, which was
designated MCPIP (as MCP-1
Induced Protein) (4). This gene
encodes a novel CCCH-zinc finger-
containing protein. By searching
similar sequences in GenBankTM,
we have found that four members
belong to this protein family that are
designated as MCPIP1, 2, 3, and 4
and encoded by four genes,
Zc3h12a, Zc3h12b, Zc3h12c, and
Zc3h12d, respectively. The obvious
feature of this protein family is that
they all contain a single CCCH-type
zinc finger (Fig. 1A). In addition to
the central CCCH-zinc finger,
MCPIP1 contains two proline-rich
domains at the N- and C-terminals,
which maymediate interaction with
Src homology 3 domain-containing
proteins. MCPIP2 has a RasGEF
domain at the C-terminal of the zinc
finger motif, suggesting its potential
involvement in signal transduction.
No other specific motifs are ob-
served in MCPIP3 and 4. It is worth
noting that the zinc finger inMCPIP
family is C(X)5C(X)5C(X)3H type
and very conserved among this fam-
ily, which is somewhat different
from the two fingers in TTP that
were C(X)8C(X)5C(X)3H type (Fig.
1B). The bioinformatics of human
and mouse MCPIP family was sum-
marized in Fig. 1C. Their mRNA
length represents the longestmRNA
in GenBankTM, which may not be
the actual full length. The protein
weight is predicted and not yet
confirmed experimentally. Proteins
containing CCCH-zinc finger have
been identified from metazoan or-
ganisms, yeast, and plant. It seems
that theMCPIP family is much con-
served during evolution as we iden-
tified cDNA sequences that encode
proteins highly similar to MCPIPs
from Drosophila melanogaster,
Caenorhabditis elegans toMusmus-
culus and Rattus norvegicus. The
homology between human and mouse MCPIPs varies from 81
to 92%. The amino acid identity between different mouse
MCPIP family members is 40%, but the homology of their
zinc finger motif is 80%. Phylogenetic analysis indicates that
MCPIP2 and MCPIP3 are more closely related to each other
than to other MCPIP family members (data not shown).
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Induction of the MCPIP Family during Macrophage
Activation—Macrophage activation is an essential cellular
process underlying innate immunity, enabling the body to com-
bat bacteria and other pathogens. In addition to host defense,
activated macrophages play a central role in atherogenesis,
autoimmunity, and a variety of inflammatory diseases. To
explore whether theMCPIP family is involved in the regulation
of macrophage activation, we examined the expression of
MCPIPs during LPS- or IFN-induced macrophage activation,
which are the most studied two inducers for macrophage acti-
vation. As shown in Fig. 2A, Northern blot revealed that both
MCPIP1 and MCPIP3 were highly induced in LPS-, but not
IFN-, stimulated murine macrophage cell line Raw264.7.
Their expression was raised after 1 h of LPS treatment, peaked
at 2 h by 20-fold above basal line, and was sustained at a high
level for at least 16 h. MCPIP4 was also induced to some extent
by LPS over a 16-h time course, whereas MCPIP2 was not
induced at all during the time periods of both LPS and IFN
stimulation. LPS also stimulated expression of MCPIP1 in
THP-1-derived macrophages over the time course of 1 to 24 h
with a pattern similar to Raw264.7 (Fig. 2B). BothMCPIP1 and
MCPIP3 were also induced by endogenous cytokines TNF
and IL-1 in THP-1 cells (Fig. 2C). We further explored the
effect of LPS on the expression of MCPIPs in mouse primary
bone marrow-derived macrophages. Consistent with the
results from Raw264.7, both MCPIP1 and MCPIP3 transcripts
increased a remarkable 25-fold over basal levels at 2 h after LPS
stimulation and then declined a little bit but sustained a sub-
stantial level for 24 h. The basal levels of both MCPIP2 and
MCPIP4 seemed very low and did not change after exposure to
LPS in the 24-h time period (Fig. 2D). To validate our LPS stim-
ulations, we also assessed the temporal expression of macro-
phage inflammatorymediators IL-1, IL-6,MCP-1, and TNF.
Consistent with the previous report, they were all potently
induced by ten- to thousands-fold after LPS treatment (Fig.
2D). It is interesting to note that with the exception of IL-1,
which constantly increased during the 24 h of stimulation, the
mRNA of IL-6, MCP-1, and TNF reached a peak at 2 or 8 h of
stimulation and then declined to basal level at 24 h, suggesting
that a negative regulatorymechanismmay terminate the proin-
flammatory signals.
Next we examined macrophage MCPIP1 protein expression
in response to LPS. Western blot analysis detected a band
around 65.5 kDa, which is the expected protein size ofMCPIP1.
MCPIP1 proteinwas increased by 8-foldwithin 8 h of LPS stim-
ulation in THP-1-derivedmacrophages (Fig. 2E). MCPIP1 pro-
tein expression was further studied using immunofluorescence
microscopy. Treatment of THP-1macrophages with LPS led to
amarked increase inMCPIP1protein expression.MCPIP1pro-
tein seems predominantly localized in the cytoplasm (Fig. 2F).
No specific staining was seen by control serum (Fig. 2G).
MCPIP1 Negatively Regulates LPS-induced Macrophage
Activation but Does Not Affect Lipid Uptake—MCPIP1was sig-
nificantly induced during LPS-inducedmacrophage activation,
suggesting that it may be involved in the regulation of this
important process. To test this idea, the murine macrophage
cell line Raw263.7 cells were transiently transfected with
pMCPIP1 or pEGFP-N1 by electroporation. Overexpression of
MCPIP1 was confirmed by microscopy as well as quantitative
FIGURE 2. Expression of MCPIP family members is induced by LPS in macrophages. A, Raw264.7 cells were treated with LPS (1 g/ml) or IFN (2 ng/ml) for
different times as indicated. Total RNA (15 g/lane) was analyzed by Northern blotting using 32P-labeled cDNA probes. Ethidium bromide-stained RNA image
served as loading control. B, THP-1 cells were differentiated into macrophages by treatment with phorbol 12-myristate 13-acetate (100 ng/ml) for 5 days. After
24 h of quiescence, the cells were treated with LPS (1 g/ml) for the indicated times. Total RNA was isolated, and Northern blotting was performed to detect
MCPIP1 expression. The same membrane was probed with glyceraldehyde-3-phosphate dehydrogenase and served as loading control. C, THP-1 cells were
quiescent for 16 h and then treated with TNF (10 ng/ml) or IL-1 (10 ng/ml) for 8 h. mRNA levels of MCPIP1 and MCPIP3 were measured by reverse
transcription PCR, and -actin served as loading control. D, monocyte progenitors from C57BL6/J mice were obtained and differentiated into primary macro-
phages. Primary macrophages were exposed to LPS (1 g/ml) and harvested at the indicated time points. Samples were processed and subjected to quanti-
tative PCR analysis. Data are from three independent experiments and normalized to -actin expression. E, THP-1 cells were differentiated into macrophages as
described above. After 24 h of quiescence, the cells were treated with LPS (1 g/ml) for the indicated times. Cell lysates were prepared and MCPIP1 protein level was
evaluated by Western blotting (40 g protein/lane) as described under “Materials and Methods.” The intensity of bands was quantified by AlphaImage 2200 (AlphaIn-
notech), and the normalized protein levels are shown (bottom). *, nonspecific bands. F and G, THP-1-derived macrophages were treated with PBS or 1 g/ml LPS for
16 h. The cells were then permeated and stained with antibody to MCPIP1 (B) or control serum (C) and counterstained with 4,6-diamidino-phenylindole (DAPI).
FIGURE 3. Overexpression of MCPIP1 inhibits LPS-induced TNF, IL-6,
and NO2
. production but does not affect lipid uptake. A, Raw264.7 cells
were transiently transfected with pEGFP-N1 or pMCPIP1 by electroporation
(Amaxa). The overexpression of MCPIP1 in the transfected cells was moni-
tored by quantitative PCR (left) and Western blotting (right). B, the transfected
cells were quiescent for 24 h and then treated with PBS or 1 g/ml LPS for 6 h.
The cultured medium was harvested for measurement of TNF, IL-6, and NO
production. Data are represented as mean  S.D., n  3. **, p 0.001. C, the
transfected Raw264.7 cells were treated with Dil-labeled ac-LDL for 6 h and
visualized by fluorescent microscopy (left) or incubated with Dil-ac-LDL for 15
and 180 min and determined by fluorometry (right). Data are represented as
mean  S.D., n  3.
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PCR and Western blot (Fig. 3A). In cells overexpressing
MCPIP1, we observed a marked reduction in the LPS-induced
production of TNF, IL-6, and NO2. (Fig. 3B). However, it was
noted that overexpression ofMCPIP1 did not affectDil-ac-LDL
uptake (Fig. 3C).
MCPIP1 Negatively Regulates LPS-induced Inflammatory
Gene Expression but Does Not Affect the Cell Surface Marker
Expression in Macrophages—Next, we further investigated the
effect of MCPIP1 on LPS-stimulated gene expression. As
shown in Fig. 4A, LPS dramatically induced inflammatory cyto-
kine (TNF, IL-1, IL-6, andMCP-1) expression by several- to
thousands-fold. Interestingly, MCPIP1 overexpression signifi-
cantly blunted the induction of TNF, IL-1, IL-6, andMCP-1
by LPS. Conversely, knocking down of MCPIP1 using specific
short interference RNA strongly augmented the induction of
TNF, IL-1, IL-6, and MCP-1 by LPS (Fig. 4A). The efficient
knocking down ofMCPIP1 by siRNAwas confirmed by North-
ern blotting (Fig. 4C). We further observed the expression
changes of TNF andMCP-1 during a time period of LPS stim-
ulation in green fluorescent protein- or MCPIP1-transfected
cells by Northern blotting. As shown in Fig. 4B, significant
decrease in TNF andMCP-1mRNAwas observed inMCPIP1
overexpressed cells after 4 h of stimulation. Consistent with the
functional examination above, MCPIP1 negatively regulated
iNOS expression but did not affect the expression of scavenger
receptor A, CD36, ABCA1, and matrix metalloproteinase-9 in
LPS-treatedmacrophages (Fig. 4D). Interestingly, although two
members of costimulatory molecule B7 family, B7-1 and B7-2,
were also substantially induced by LPS in macrophages, over-
expression of MCPIP1 inhibited B7-1, but not B7-2, induction
(Fig. 4, E and F).
MCPIP1 Does Not Affect mRNA Degradation of Inflamma-
tory Cytokines—The expression of inflammatory cytokines,
including TNF, IL-1, IL-6, andMCP-1, is tightly regulated at
both transcriptional and posttranscriptional levels. It is noted
that the TTP family, a well studied CCCH-zinc finger protein
family, can bind to the ARE at the 3-untranslated region of
TNF mRNA and promote its decay (7–9). To explore the
mechanisms of the MCPIP1 effect on inflammatory cytokines,
we first evaluated the potential influence of MCPIP1 on the
mRNA stability of TNF and MCP-1 in LPS-stimulated
Raw264.7 cells. In the experiment shown in Fig. 5A, the cells
were stimulated with LPS (1 g/ml; Sigma) for 8 h and then
treated with actinomycin D (5 g/ml; Sigma). The RNA was
isolated at different time points as indicated. Surprisingly,
although both TNF and MCP-1 mRNA levels were signifi-
cantly decreased inMCPIP1-overexpressing cells, the half-lives
of both TNF andMCP-1mRNAwere barely affected by over-
expression of MCPIP1 (48 and 110 min versus 44 and 100 min,
respectively). These results cannot explainwhyMCPIP1 down-
regulate the inflammatory cytokine expression. However, there
is a possibility that MCPIP1 may work with one or more other
inducible proteins to promotemRNAdecay and that actinomy-
cin D may block the expression of those proteins to diminish
their effect. To exclude this possibility, we performed an ARE-
mediated mRNA decay assay in human HeLa Tet-off cells as
described previously (12). Basically, two -globin reporters,
Wt (containing human -globin gene) or Wt-TNF (con-
taining -globin gene and the potent ARE from TNF mRNA
in the 3-untranslated region), were co-transfected with
pMCPIP1 or pEGFP-N1 into the HeLa Tet-off cell line (both
the reporters and the HeLa Tet-off cell line were kindly pro-
vided by Dr. Jens Lykke-Andersen). Transcription of the -glo-
bin mRNA is controlled by a tetracycline regulatory promoter
that allows for measurement of the mRNA decay rate in pulse-
chase experiments in human HeLa Tet-off cells. The results in
Fig. 5B showed thatMCPIP1 did not affect the ARE-containing
-globin mRNA decay. These results indicate that MCPIP1
does not directly regulate TNF mRNA stability.
MCPIP1 Negatively Regulates the TNF and iNOS Promoter
and Blocks LPS-induced NF-B Activation—We then asked
whether MCPIP1 regulate the promoter activity of the inflam-
matory genes. For these studies, we used a1.2-kb fragment of
themouseTNF promoter and1.5-kb fragment of themouse
iNOS promoter. These promoters contain all of the regulatory
elements necessary for LPS responsiveness in vivo (13, 14). As
shown in Fig. 6A, forced expression of MCPIP1 dose depen-
dently inhibited LPS-induced promoter activity of TNF and
iNOS. As NF-B is a key transcription factor to regulate both
TNF and iNOS promoters, we tested whetherMCPIP1 would
also inhibit p65-induced TNF and iNOS promoter activation.
As shown in Fig. 6B, MCPIP1 also significantly decreased both
p65-induced TNF and iNOS promoter activity in a dose-de-
pendent manner. Finally, we asked whether MCPIP1 can block
LPS-induced NF-B activation. As expected, LPS or p65 mark-
edly induced NF-B mini promoter activation (Fig. 6C),
whereasMCPIP1 strongly blocked LPS- or p65-inducedNF-B
activation. This effect was specific, because MCPIP1 did not
block peroxisome proliferator-activator receptor -induced
PPRE promoter activation (Fig. 6C). These results strongly
suggest that MCPIP1 may function as a feedback inhibitor
for LPS-induced NF-B signaling, by which it negatively reg-
ulates inflammatory gene expression as well as macrophage
activation.
DISCUSSION
In an effort to searchMCP-1-induced genes in humanmono-
cytes, we previously identified a highly MCP-1-induced pro-
FIGURE 4. MCPIP1 regulates a distinct group of inflammatory gene expression. A, in the overexpression experiments, Raw264.7 cells were transiently
transfected with pEGFP-N1 or pMCPIP1 by electroporation (Amaxa). In the knocking down experiments, Raw264.7 cells were transiently transfected with short
interfering RNA targeting MCPIP1 (siMCPIP1) or nonspecific short interfering RNA (siControl) by electroporation (Amaxa). The transfected cells were quiescent
for 24 h and then treated with PBS or 1 g/ml LPS for 8 h. RNA was isolated for quantitative PCR analysis. *, p  0.05; **, p  0.001. B, RNA samples from the
overexpression experiments were further subjected to Northern blot analysis. The image for 28 S RNA served as loading control. C, RNA samples from the
knocking down experiments were further subjected to Northern blot analysis. The image for 28 S RNA served as loading control. D and E, the RNA samples from
overexpression experiments were analyzed by quantitative PCR for some other gene expression as indicated. Data were normalized by -actin and are
represented as mean  S.D., n  3. F, Raw264.7 cells were transiently transfected with pEGFP-N1 or pMCPIP1 by electroporation (Amaxa). The transfected cells
were quiescent for 24 h and then stimulated with LPS (1 g/ml) for 26 h. Protein was isolated and analyzed by Western blot using goat anti-B7-1 polyclonal antibody.
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tein, MCPIP. In this study, we have found that there are four
members,MCPIP1, 2, 3, and 4, belonging to this subfamily. The
obvious feature of this protein family is that they all contain a
single CCCH-type zinc finger motif and their transcripts were
enriched in immune organ as well as other organs (data not
shown). As a start, here we characterizedMCPIP1 as a negative
regulator of LPS-dependent macrophage activation.
CCCH-type zinc finger is unusual in mammalian genomes.
Searching the protein data base, we found 58 CCCH-type zinc
finger proteins in human and
murine genomes.3 Most of them
were not characterized yet. Among
the characterized CCCH-type zinc
finger proteins, most are capable of
binding toRNAand regulatemRNA
processing, including mRNA matu-
ration, export, modification, and
turnover (15, 16). TTP is the proto-
type of a family of CCCH-zinc fin-
ger proteins that contain two
(CX)8(CX)5(CX)3H-type zinc finger
motifs. Although initially discov-
ered as a gene that could be induced
rapidly and transiently by the stim-
ulation of fibroblasts with growth
factors and mitogens (17), it is now
known that TTP can bind to AU-
rich elements in mRNA, leading to
the removal of the poly(A) tail from
that mRNA and increased rates of
mRNA turnover. TTP-deficient
mice developed a systemic inflam-
matory syndrome with severe pol-
yarticular arthritis and autoimmu-
nity, as well as medullary and
extramedullarymyeloid hyperplasia
due to excess circulating TNF,
resulting from the increased stabil-
ity of the TNF mRNA and subse-
quent higher rates of secretion of
the cytokine (18). We originally
hypothesized thatMCPIP1may also
down-regulate the expression of
proinflammatory genes through
promoting their mRNA decay. Two
approaches were used to examine
the effect of MCPIP1 on TNF
mRNA decay and show that
MCPIP1 does not affect TNF
mRNA stability at all. Therefore,
theMCPIP family may function in a
different way than other CCCH-
zinc finger families.
We then looked at the impact of
MCPIP1 on LPS-induced TNF
promoter activation. Interestingly,
forced expression ofMCPIP1 signif-
icantly inhibited LPS-stimulated
TNF promoter activation. Similar results were observed in the
iNOS promoter. These results may explain why overexpression
ofMCPIP1 dramatically attenuated LPS-induced expression of
TNF and iNOS as well as LPS-induced NO2. synthesis and
TNF production in macrophages. The major direct signal
pathway formacrophage activation by LPS is the NF-B signal-
3 J. Liang and M. Fu, unpublished data.
FIGURE 5. Effect of MCPIP1 on TNF and MCP-1 mRNA stability in macrophages. A, Raw264.7 cells were
transiently transfected with pEGFP-N1 or pMCPIP1 by electroporation. After 24 h, the cells were quiescent for
18 h and then treated with LPS (1 g/ml) for 8 h, and then actinomycin D (5 g/ml) was added to stop
transcription. RNA was harvested after different time points as indicated. TNF and MCP-1 mRNA levels were
examined by Northern blot. The intensity of bands was quantified by AlphaImage 2200 (AlphaInnotech). The
value of 0 time point was set as 100%, and the values of the other points were transformed according to 0 point.
The data from three independent experiments were averaged and plotted in the figures at the bottom of each
image. B, HeLa Tet-off cells were transfected with Wt or Wt-TNFARE reporter with or without pEGFP-N1 or
pMCPIP1 as indicated by FuGENE 6, in the presence of doxycycline. After 24 h, the cells were washed with PBS
and incubated with medium without doxycycline for 6 h, and then doxycycline (3 g/ml) was added to stop
transcription of the reporter. RNA was harvested after different time points as indicated. -Globin mRNA level
was examined and analyzed by the same procedure as above.
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ing pathway (19). To further understand the molecular mech-
anisms by which MCPIP1 regulates the proinflammatory
response of macrophages to LPS, we observed the effect of
MCPIP1 on LPS-dependent NF-B activation. Overexpression
of MCPIP1 inhibited LPS-triggered NF-B activation, but not
rosiglitazone-induced proliferator-activator receptor  activa-
tion, suggesting that MCPIP1 may be a novel inhibitor of the
NF-B activation pathways (Fig. 6). In addition, overexpression
of MCPIP1 inhibited p65-induced activation of the TNF pro-
moter, iNOS promoter, and NF-B mini promoter, suggesting
that MCPIP1 may directly target
p65. Interestingly, although LPS
also significantly induced expres-
sion of themacrophage surface pro-
tein scavenger receptor A and
secreted enzyme matrix metallo-
proteinase 9, overexpression of
MCPIP1 did not affect their induc-
tion at all. Because the major signal
pathway contributing to scavenger
receptor A and matrix metallopro-
teinase 9 induction is p38 kinase-ac-
tivator protein-1 (AP-1) pathway
(14, 20), we reason that MCPIP1
may selectively target LPS-induced
NF-B signal pathway but not AP-1
signaling. This notion is further
supported by the observation of two
costimulatory molecules, B7-1 and
B7-2. B7-1 and B7-2 are related
immunoglobulin supergene family
members that are expressed bymul-
tiple cell types, including mono-
cytes, macrophages, B cells, and T
cells, following activation (21). Both
B7-1 and B7-2 were induced by LPS
in macrophages. B7-1 induction is
dependent on NF-B signaling,
whereas B7-2 induction is inde-
pendent ofNF-B signaling (22, 23).
We observed that MCPIP1 blocked
B7-1, but not B7-2, induction by
LPS, suggesting MCPIP1 may func-
tion as a specific inhibitor forNF-B
signaling.
Considering that MCPIP1 is
induced by a range of inflammatory
stimuli such as LPS, TNF, IL-1,
and MCP-1, we conclude that
MCPIP1may function as a feedback
inhibitor of macrophage activation
by targeting to NF-B signaling.
Currently, the detailed mechanisms
whereby MCPIP1 inhibits NF-B
activation are unknown. Several
NF-B inhibitors recently identi-
fied, such as suppressor of cytokine
signaling 1 (SOCS1), A-20, Bcl-3,
FLN29, and PDLIM2, down-regulate NF-B signaling by tar-
geting to NF-B ubiquitination pathway (24–28). At least two
CCCH-zinc finger-containing proteins, Roquin andmarkrin-1,
function as ubiquitin ligase (11, 29). A study to determine
whether MCPIP1 also target the NF-B ubiquitination system
is under way.
Currently, the function of the other three members in the
MCPIP family remains to be determined. MCPIP2 was highly
expressed in brain, thymus, and testis under normal conditions
(data not shown) but not expressed in LPS- or IFN-activated
FIGURE 6. MCPIP1 negatively regulates the TNF and iNOS promoters and blocks LPS-induced NF-B
activation. A, Raw264.7 cells were co-transfected with a luciferase reporter plasmid under transcriptional
control of the TNF or iNOS promoters and increasing amounts of pMCPIP1 (0, 5, 50, and 500 ng/well). After
being quiescent for 24 h, cells were treated with or without LPS (100 ng/ml) as shown and collected for analysis
of reporter gene activity 24 h later. B, Raw264.7 cells were co-transfected with the TNF or iNOS reporter, p65,
and increasing amounts of pMCPIP1 (0, 5, 50, and 500 ng/well). C, Raw264.7 cells were co-transfected with an
NF-B or PPRE mini reporter and increasing amounts of pMCPIP1 (0, 5, 50, and 500 g/well). NF-B reporter was
stimulated by LPS (100 ng/ml) or induced by co-transfection with p65, whereas PPRE reporter was stimulated
by proliferator-activator receptor  co-transfection and treatment with rosiglitazone (1 M). Cells were col-
lected for analysis of reporter gene activity 24 h later.
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macrophages. Besides a central CCCH-zinc finger motif, it has
a RasGEF domain, suggesting that it may be involved in Ras-
mediated signal transduction. MCPIP3 has a different tissue
expression pattern thanMCPIP1, but they have a similar induc-
tion in LPS-induced macrophage activation. MCPIP4 is specif-
ically abundant in spleen, intestine, and colon and also induced
to some extent by LPS in Raw264.7 cells. Further studies are
needed to characterize their function.
It is well established that uncontrolled inflammation does
not benefit organisms but instead causes tissue impairment.
Manymechanisms have been evolved to control the intensity of
pathogen-initiated inflammatory response through negative
feedback. In this sense, the MCPIP protein family may be crit-
ically involved in the regulation of macrophage activation and
implicated in pathogenesis of inflammatory diseases. Our pre-
vious works have demonstrated that MCPIP1 transcript level
was much higher in explanted human hearts with ischemic
heart disease (4) and adipose tissues from diet-induced obese
mice,4 both of the conditions having inflammatory status.
Future studies will help to elucidate the importance and mech-
anisms of the MCPIP family in human inflammatory diseases.
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